gut microbiota
A gut microbial metabolite called trimethylamine N-oxide, or TMAO, could improve immunotherapy success in pancreatic cancer.
The findings of a new research suggest that microbiota-based therapies can help improve clinical outcomes after organ transplants.
Researchers have developed a new technique that can identify which gut microbes have migrated from the gut to the blood.
Denise Kelly (Investment Advisor at Seventure) discussed the next challenges and opportunities in the field of gut microbiome therapeutics.
A recent study shows that some bacterial strains are similar to the human host phylogeny, suggesting that they evolved alongside humans.
The findings of a new study suggest that Bacteroides can metabolize cholesterol, thus helping to regulate its levels in the blood.
Together with Prof. Ted Dinan (UCC Ireland), in this episode we discuss the link between gut, insomnia and anxiety.
The findings of a recent study suggest that phages can be used to treat IBD and other diseases associated with gut microbes.
Ghaith Bakdash described how Microbiotica discovered a specific microbiome signature in patients responder to immune-oncology drugs such as anti-PD1 / PDL1 and developed a new bacterial consortium.
The findings of a recent study suggest that engineered native gut bacteria could be employed to help treat certain diseases such as diabetes.
